While CEO-designate Vas Narasimhan kept tightlipped on this point in the press conference, an answer came a few hours later, with a deal with groundbreaking gene therapy company Spark Therapeutics ...

Novartis’ Vas Narasimhan I spoke to Novartis’ head of drug development Vas Narasimhan in depth about the company’s CAR-T programme a few weeks ago, ahead of Kite’s latest announcement.

Tmunity Therapeutics, with ties to Penn Medicine, once raised $231 million from investors. Now workers and its Center City office are gone.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device ...

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for ...

Find the latest stock market news from every corner of the globe at Reuters.com, your online source for breaking international market and finance news ...

Markets InformationCharts and financial information provided by TradingView, a popular charting & trading platform. Check out even more advanced features or grab charts for your website.